Tag Archives: intellectual property

New Webinar Series: Practical IP for Natural Sciences

Please join us in a new webinar series directed to the practical strategies in a new era of patent law to protect IP in chemistry, pharmaceuticals, biotechnology and genetic medicine. The collision of new technologies and patent statutes of a … Continue reading

Posted in Webinar | Tagged , , , , , , | Leave a comment

USPTO Post-Prosecution Pilot Program Launches

A guest post from Edward Sandor, attorney at Schwegman. The Post-Prosecution Pilot Program (P3) launched at the USPTO Monday, combining features of the AFCP 2.0 and Pre-Appeal Brief Conference Pilot programs, with the notable addition of Applicant participation in the process. … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

FDA Releases Outline of Guidance for Developing Tests Based on Human Genetic Variants

The FDA is charged with regulating “Next Generation Sequencing (NGS) Tests,” and has just released draft guidance on what needs to be regulated. (A copy of the first draft and second draft can be found at the end of this … Continue reading

Posted in Patentable Subject Matter, Uncategorized | Tagged , , , , , | Leave a comment

Rapid Litigation v. CellzDirect – A Break in the 101 Wall

On July 5, 2016, a three – judge Fed. Circuit panel of Moore, Prost and Stoll (Appeal no. 2015-1570) reversed the district court’s holding that claims to a method of isolating “hardy” twice -frozen hepatocytes (as I called them in my … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , | 1 Comment